Literature DB >> 1803512

In vivo platelet activation in diabetes mellitus.

A Strano1, G Davì, C Patrono.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1803512     DOI： 10.1055/s-2007-1002648

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  8 in total

1.  Functional expression of IgA receptor FcalphaRI on human platelets.

Authors:  Kun Qian; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly; Jianming Wu
Journal:  J Leukoc Biol       Date:  2008-09-10       Impact factor: 4.962

Review 2.  Endothelial function. General considerations.

Authors:  H Haller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  A risk-benefit assessment of abciximab in angioplasty.

Authors:  N S Kleiman
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 4.  The role of glycoprotein IIb/IIIa-receptor antagonists in diabetics.

Authors:  Kurt Huber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

5.  Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision.

Authors:  Antonio Sergio Rocha; Paulo Dutra; Andrea De Lorenzo
Journal:  Curr Cardiol Rev       Date:  2010-11

Review 6.  Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates.

Authors:  G D Johnston
Journal:  Ulster Med J       Date:  1998-11

Review 7.  Preeclampsia and Extracellular Vesicles.

Authors:  Sarwat I Gilani; Tracey L Weissgerber; Vesna D Garovic; Muthuvel Jayachandran
Journal:  Curr Hypertens Rep       Date:  2016-09       Impact factor: 5.369

8.  Long-term clinical benefits of a platelet glycoprotein IIb/IIIa receptor blocker, abciximab (ReoPro), in high-risk diabetic patients undergoing percutaneous coronary intervention.

Authors:  Doo Sun Sim; Myung Ho Jeong; Weon Kim; Jay Young Rhew; Ju Hyup Yum; Ju Han Kim; Jeong Gwan Cho; Young Keun Ahn; Jong Chun Park; Byoung Hee Ahn; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.